Fulgent Genetics
FLGT
163 hedge funds and large institutions have $389M invested in Fulgent Genetics in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 22 closing their positions.
10,247% more call options, than puts
Call options by funds: $10.7M | Put options by funds: $103K
20% more capital invested
Capital invested by funds: $323M → $389M (+$66.1M)
2.87% more ownership
Funds ownership: 53.41% → 56.28% (+2.9%)
4% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 53
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less funds holding
Funds holding: 167 → 163 (-4)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$16.7M |
| 2 |
JP Morgan Chase
New York
|
+$5.45M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.56M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.88M |
| 5 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.78M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.58M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.08M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$1.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.13M |
FLGT Hedge Fund Activity: Q3 2025 in Review
163 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2025, worth a combined $389M — up 20% from $323M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of FLGT and 19 opened new positions — a net loss of 3 holders — while 53 trimmed existing stakes and 55 added.
The largest buyer was BlackRock, adding an estimated $16.7M. The largest seller was Citadel Advisors, cutting an estimated $4.78M.
- 163 institutional investors held Fulgent Genetics (FLGT) as of Q3 2025, down from 167 in Q2 2025.
- Funds reported $389M of Fulgent Genetics stock for Q3 2025, up 20% quarter-over-quarter.
- 19 funds opened new Fulgent Genetics positions in Q3 2025 and 22 closed out, a net change of -3 holders.
- The largest Fulgent Genetics buyer in Q3 2025 was BlackRock, an estimated $16.7M added.
- The largest Fulgent Genetics seller in Q3 2025 was Citadel Advisors, an estimated $4.78M sold.
Based on aggregated 13F filings for Q3 2025.